Kolon to acquire 118,040 shares of subsidiary Kolon TissueGene

Kolon announced plans to acquire 118,040 shares of its subsidiary Kolon TissueGene for 60 billion won, increasing its stake to 39.4%. The acquisition aims to support Kolon TissueGene's operating funds and clinical trial costs.

Kolon Global Corp (003070)

Kolon to issue 60 billion won exchangeable bonds

Kolon announced plans to issue 60 billion won in exchangeable bonds to acquire securities of other companies. The bonds will mature in 2031 with a 0% interest rate.

Kolon Global Corp (003070)

Kolon TissueGene raises 60 billion won through 2026 rights issue

Kolon TissueGene announced a rights issue to raise 60 billion won in operating funds on March 6, 2026. The new shares will be issued at 508,325 won each through third-party allotment.

Kolon Global Corp (003070)

Kolon Tissuegene, Inc.